Helicobacter pylori CagA and gastric cancer: A paradigm for hit-and-run carcinogenesis

Cell Host and Microbe

Volumn 15, Issue 3, 2014, Pages 306-316

  Hatakeyama, Masanori ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; ONCOPROTEIN;

BACTERIAL GENE; CAGA GENE; CANCER CELL; CARCINOGENESIS; EPIGENETICS; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; GENETIC STABILITY; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; TYPE IV SECRETION SYSTEM;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CARCINOGENS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH NEOPLASMS; VIRULENCE FACTORS;

EID: 84896078858     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2014.02.008     Document Type: Review

References (90)

1. Amieva, M.R., Vogelmann, R., Covacci, A., Tompkins, L.S., Nelson, W.J., and Falkow, S. (2003). Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300, 1430-1434. (Pubitemid 36638162)
2. Backert, S., and Naumann, M. (2010). What a disorder: proinflammatory signaling pathways induced by Helicobacter pylori. Trends Microbiol. 18, 479-486.
3. Bagnoli, F., Buti, L., Tompkins, L., Covacci, A., and Amieva, M.R. (2005). Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc. Natl. Acad. Sci. USA 102, 16339-16344. (Pubitemid 41688915)
4. Basso, D., Zambon, C.F., Letley, D.P., Stranges, A., Marchet, A., Rhead, J.L., Schiavon, S., Guariso, G., Ceroti, M., Nitti, D., et al. (2008). Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology 135, 91-99. (Pubitemid 351899019)
5. Bauer, B., Pang, E., Holland, C., Kessler, M., Bartfeld, S., and Meyer, T.F. (2012). The Helicobacter pylori virulence effector CagA abrogates human b-defensin 3 expression via inactivation of EGFR signaling. Cell Host Microbe 11, 576-586.
6. Bessède, E., Staedel, C., Acuña Amador, L.A., Nguyen, P.H., Chambonnier, L., Hatakeyama, M., Belleannée, G., Mégraud, F., and Varon, C. (2013). Helicobacter pylori generates cells with cancer stem cell properties via epithelialmesenchymal transition-like changes. Oncogene. http://dx.doi.org/10.1038/onc.2013.380.
7. Botham, C.M., Wandler, A.M., and Guillemin, K. (2008). A transgenic Drosophila model demonstrates that the Helicobacter pylori CagA protein functions as a eukaryotic Gab adaptor. PLoS Pathog. 4, e1000064.
8. Buti, L., Spooner, E., Van der Veen, A.G., Rappuoli, R., Covacci, A., and Ploegh, H.L. (2011). Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host. Proc. Natl. Acad. Sci. USA 108, 9238-9243.
9. Chan, R.J., and Feng, G.S. (2007). PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase. Blood 109, 862-867. (Pubitemid 46220628)
10. Chuang, L.S., and Ito, Y. (2010). RUNX3 is multifunctional in carcinogenesis of multiple solid tumors. Oncogene 29, 2605-2615.
11. Clements, W.M., Wang, J., Sarnaik, A., Kim, O.J., MacDonald, J., Fenoglio-Preiser, C., Groden, J., and Lowy, A.M. (2002). b-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 62, 3503-3506. (Pubitemid 34651399)
12. Correa, P. (1988). A human model of gastric carcinogenesis. Cancer Res. 48, 3554-3560.
13. Cover, T.L., and Blaser, M.J. (2009). Helicobacter pylori in health and disease. Gastroenterology 136, 1863-1873.
14. Deng, N., Goh, L.K., Wang, H., Das, K., Tao, J., Tan, I.B., Zhang, S., Lee, M., Wu, J., Lim, K.H., et al. (2012). A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 61, 673-684.
15. Ekström, A.M., Held, M., Hansson, L.-E., Engstrand, L., and Nyrén, O. (2001). Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 121, 784-791.
16. Ferreira, R.M., Machado, J.C., Leite, M., Carneiro, F., and Figueiredo, C. (2012). The number of Helicobacter pylori CagA EPIYA C tyrosine phosphorylation motifs influences the pattern of gastritis and the development of gastric carcinoma. Histopathology 60, 992-998.
17. Fischer, W. (2011). Assembly and molecular mode of action of the Helicobacter pylori Cag type IV secretion apparatus. FEBS J. 278, 1203-1212.
18. Franco, A.T., Israel, D.A., Washington, M.K., Krishna, U., Fox, J.G., Rogers, A.B., Neish, A.S., Collier-Hyams, L., Perez-Perez, G.I., Hatakeyama, M., et al. (2005). Activation of b-catenin by carcinogenic Helicobacter pylori. Proc. Natl. Acad. Sci. USA 102, 10646-10651. (Pubitemid 41061608)
19. Fujii, Y., Yoshihashi, K., Suzuki, H., Tsutsumi, S., Mutoh, H., Maeda, S., Yamagata, Y., Seto, Y., Aburatani, H., and Hatakeyama, M. (2012). CDX1 confers intestinal phenotype on gastric epithelial cells via induction of stemness-associated reprogramming factors SALL4 and KLF5. Proc. Natl. Acad. Sci. USA 109, 20584-20589.
20. Furth, P.A. (2012). Cancer prevention as biomodulation: targeting the initiating stimulus and secondary adaptations. Ann. N Y Acad. Sci. 1271, 1-9.
21. Hatakeyama, M. (2003). Helicobacter pylori CagA-a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. Microbes Infect. 5, 143-150.
22. Hatakeyama, M. (2004). Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat. Rev. Cancer 4, 688-694.
23. Hatakeyama, M. (2011). Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein. Cancer Sci. 102, 36-43.
24. + leakage, up-regulation of interleukin-1β, and atrophic gastritis in mice. Gastroenterology 142, 292-304.
25. Hayashi, T., Senda, M., Morohashi, H., Higashi, H., Horio, M., Kashiba, Y., Nagase, L., Sasaya, D., Shimizu, T., Venugopalan, N., et al. (2012b). Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe 12, 20-33.
26. Hayashi, T., Morohashi, H., and Hatakeyama, M. (2013). Bacterial EPIYA effectors-where do they come from? What are they? Where are they going? Cell. Microbiol. 15, 377-385.
27. Higashi, H., Tsutsumi, R., Muto, S., Sugiyama, T., Azuma, T., Asaka, M., and Hatakeyama, M. (2002). SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science 295, 683-686. (Pubitemid 34111828)
28. Higashi, H., Yokoyama, K., Fujii, Y., Ren, S., Yuasa, H., Saadat, I., Murata-Kamiya, N., Azuma, T., and Hatakeyama, M. (2005). EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor CagA in mammalian cells. J. Biol. Chem. 280, 23130-23137. (Pubitemid 40853224)
29. Huang, F.Y., Chan, A.O., Rashid, A., Wong, D.K., Cho, C.H., and Yuen, M.F. (2012). Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1b activation of nitric oxide production in gastric cancer cells. Cancer 118, 4969-4980.
30. Humar, B., and Guilford, P. (2009). Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci. 100, 1151-1157.
31. Jang, B.G., and Kim, W.H. (2011). Molecular pathology of gastric carcinoma. Pathobiology 78, 302-310.
32. Kaplan-Türköz, B., Jiménez-Soto, L.F., Dian, C., Ertl, C., Remaut, H., Louche, A., Tosi, T., Haas, R., and Terradot, L. (2012). Structural insights into Helicobacter pylori oncoprotein CagA interaction with b1 integrin. Proc. Natl. Acad. Sci. USA 109, 14640-14645.
33. Lee, D.C., and Jia, Z. (2009). Emerging structural insights into bacterial tyrosine kinases. Trends Biochem. Sci. 34, 351-357.
34. Lee, I.O., Kim, J.H., Choi, Y.J., Pillinger, M.H., Kim, S.Y., Blaser, M.J., and Lee, Y.C. (2010). Helicobacter pylori CagA phosphorylation status determines the gp130-activated SHP2/ERK and JAK/STAT signal transduction pathways in gastric epithelial cells. J. Biol. Chem. 285, 16042-16050.
35. Lee, K.S., Kalantzis, A., Jackson, C.B., O'Connor, L., Murata-Kamiya, N., Hatakeyama, M., Judd, L.M., Giraud, A.S., and Menheniott, T.R. (2012). Helicobacter pylori CagA triggers expression of the bactericidal lectin REG3g via gastric STAT3 activation. PLoS ONE 7, e30786.
36. Leung, S.Y., Yuen, S.T., Chung, L.P., Chu, K.M., Chan, A.S., and Ho, J.C. (1999). hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res. 59, 159-164. (Pubitemid 29062972)
37. Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., et al. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715. (Pubitemid 351636299)
38. Marusawa, H., and Chiba, T. (2010). Helicobacter pylori-induced activation-induced cytidine deaminase expression and carcinogenesis. Curr. Opin. Immunol. 22, 442-447.
39. Matozaki, T., Murata, Y., Saito, Y., Okazawa, H., and Ohnishi, H. (2009). Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation. Cancer Sci. 100, 1786-1793.
40. Mimuro, H., Suzuki, T., Tanaka, J., Asahi, M., Haas, R., and Sasakawa, C. (2002). Grb2 is a key mediator of helicobacter pylori CagA protein activities. Mol. Cell 10, 745-755. (Pubitemid 35335631)
41. Miura, M., Ohnishi, N., Tanaka, S., Yanagiya, K., and Hatakeyama, M. (2009). Differential oncogenic potential of geographically distinct Helicobacter pylori Cag A isoforms in mice. Int. J. Cancer 125, 2497-2504.
42. Mueller, D., Tegtmeyer, N., Brandt, S., Yamaoka, Y., De Poire, E., Sgouras, D., Wessler, S., Torres, J., Smolka, A., and Backert, S. (2012). c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains. J. Clin. Invest. 122, 1553-1566.
43. Murakami, K., Fujioka, T., Okimoto, T., Mitsuishi, Y., Oda, T., Nishizono, A., and Nasu, M. (1999). Analysis of p53 gene mutations in Helicobacter pyloriassociated gastritis mucosa in endoscopic biopsy specimens. Scand. J. Gastroenterol. 34, 474-477. (Pubitemid 29307816)
44. Murata-Kamiya, N., Kurashima, Y., Teishikata, Y., Yamahashi, Y., Saito, Y., Higashi, H., Aburatani, H., Akiyama, T., Peek, R.M., Jr., Azuma, T., and Hatakeyama, M. (2007). Helicobacter pylori CagA interacts with E-cadherin and deregulates the β-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26, 4617-4626. (Pubitemid 47067401)
45. Murata-Kamiya, N., Kikuchi, K., Hayashi, T., Higashi, H., and Hatakeyama, M. (2010). Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 7, 399-411.
46. Nagase, L., Murata-Kamiya, N., and Hatakeyama, M. (2011). Potentiation of Helicobacter pylori CagA protein virulence through homodimerization. J. Biol. Chem. 286, 33622-33631.
47. Neal, J.T., Peterson, T.S., Kent, M.L., and Guillemin, K. (2013). H. pylori virulence factor CagA increases intestinal cell proliferation by Wnt pathway activation in a transgenic zebrafish model. Dis. Model. Mech. 6, 802-810.
48. Nesić, D., Miller, M.C., Quinkert, Z.T., Stein, M., Chait, B.T., and Stebbins, C.E. (2010). Helicobacter pylori CagA inhibits PAR1-MARK family kinases by mimicking host substrates. Nat. Struct. Mol. Biol. 17, 130-132.
49. Niller, H.H., Wolf, H., and Minarovits, J. (2011). Viral hit and run-oncogenesis: genetic and epigenetic scenarios. Cancer Lett. 305, 200-217.
50. O'Gorman, A., Colleran, A., Ryan, A., Mann, J., and Egan, L.J. (2010). Regulation of NF-kappaB responses by epigenetic suppression of IkappaBalpha expression in HCT116 intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 299, G96-G105.
51. Ohnishi, N., Yuasa, H., Tanaka, S., Sawa, H., Miura, M., Matsui, A., Higashi, H., Musashi, M., Iwabuchi, K., Suzuki, M., et al. (2008). Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. USA 105, 1003-1008. (Pubitemid 351282071)
52. Olivier, M., Hollstein, M., and Hainaut, P. (2010). TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb. Perspect. Biol. 2, a001008.
53. Parkin, D.M. (2004). International variation. Oncogene 23, 6329-6340.
54. Peek, R.M., Jr., and Blaser, M.J. (2002). Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2, 28-37.
55. Piazzi, G., Fini, L., Selgrad, M., Garcia, M., Daoud, Y., Wex, T., Malfertheiner, P., Gasbarrini, A., Romano, M., Meyer, R.L., et al. (2011). Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer. Oncotarget 2, 1291-1301.
56. Ren, S., Higashi, H., Lu, H., Azuma, T., and Hatakeyama, M. (2006). Structural basis and functional consequence of Helicobacter pylori CagA multimerization in cells. J. Biol. Chem. 281, 32344-32352. (Pubitemid 46036789)
57. Rieder, G., Merchant, J.L., and Haas, R. (2005). Helicobacter pylori cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 128, 1229-1242. (Pubitemid 40712175)
58. Saadat, I., Higashi, H., Obuse, C., Umeda, M., Murata-Kamiya, N., Saito, Y., Lu, H., Ohnishi, N., Azuma, T., Suzuki, A., et al. (2007). Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447, 330-333. (Pubitemid 46788831)
59. Safari, F., Murata-Kamiya, N., Saito, Y., and Hatakeyama, M. (2011). Mammalian Pragmin regulates Src family kinases via the Glu-Pro-Ile-Tyr-Ala (EPIYA) motif that is exploited by bacterial effectors. Proc. Natl. Acad. Sci. USA 108, 14938-14943.
60. Saito, Y., Murata-Kamiya, N., Hirayama, T., Ohba, Y., and Hatakeyama, M. (2010). Conversion of Helicobacter pylori CagA from senescence inducer to oncogenic driver through polarity-dependent regulation of p21. J. Exp. Med. 207, 2157-2174.
61. Saito-Diaz, K., Chen, T.W., Wang, X., Thorne, C.A., Wallace, H.A., Page-McCaw, A., and Lee, E. (2013). The way Wnt works: components and mechanism. Growth Factors 31, 1-31.
62. Satomi, S., Yamakawa, A., Matsunaga, S., Masaki, R., Inagaki, T., Okuda, T., Suto, H., Ito, Y., Yamazaki, Y., Kuriyama, M., et al. (2006). Relationship between the diversity of the cagA gene of Helicobacter pylori and gastric cancer in Okinawa, Japan. J. Gastroenterol. 41, 668-673. (Pubitemid 44288531)
63. Segal, E.D., Cha, J., Lo, J., Falkow, S., and Tompkins, L.S. (1999). Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc. Natl. Acad. Sci. USA 96, 14559-14564. (Pubitemid 30000689)
64. Selbach, M., Paul, F.E., Brandt, S., Guye, P., Daumke, O., Backert, S., Dehio, C., and Mann, M. (2009). Host cell interactome of tyrosine-phosphorylated bacterial proteins. Cell Host Microbe 5, 397-403.
65. Shanks, A.M., and El-Omar, E.M. (2009). Helicobacter pylori infection, host genetics and gastric cancer. J. Dig. Dis. 10, 157-164.
66. Sheh, A., and Fox, J.G. (2013). The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes 4, 505-531.
67. Sherr, C.J., and Weber, J.D. (2000). The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10, 94-99. (Pubitemid 30113711)
68. Simister, P.C., and Feller, S.M. (2012). Order and disorder in large multi-site docking proteins of the Gab family-implications for signalling complex formation and inhibitor design strategies. Mol. Biosyst. 8, 33-46.
69. Skinner, G.R. (1976). Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a "hit and run" mechanism. Br. J. Exp. Pathol. 57, 361-376.
70. Suzuki, A., and Ohno, S. (2006). The PAR-aPKC system: lessons in polarity. J. Cell Sci. 119, 979-987.
71. Suzuki, M., Mimuro, H., Suzuki, T., Park, M., Yamamoto, T., and Sasakawa, C. (2005). Interaction of CagA with Crk plays an important role in Helicobacter pylori-induced loss of gastric epithelial cell adhesion. J. Exp. Med. 202, 1235-1247. (Pubitemid 41586954)
72. Suzuki, M., Mimuro, H., Kiga, K., Fukumatsu, M., Ishijima, N., Morikawa, H., Nagai, S., Koyasu, S., Gilman, R.H., Kersulyte, D., et al. (2009). Helicobacter pylori CagA phosphorylation-independent function in epithelial proliferation and inflammation. Cell Host Microbe 5, 23-34.
73. Takahashi, A., Tsutsumi, R., Kikuchi, I., Obuse, C., Saito, Y., Seidi, A., Karisch, R., Fernandez, M., Cho, T., Ohnishi, N., et al. (2011). SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver. Mol. Cell 43, 45-56.
74. Tan, S., Tompkins, L.S., and Amieva, M.R. (2009). Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche. PLoS Pathog. 5, e1000407.
75. Tan, S., Noto, J.M., Romero-Gallo, J., Peek, R.M., Jr., and Amieva, M.R. (2011). Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog. 7, e1002050.
76. Tanaka, H., Katoh, H., and Negishi, M. (2006). Pragmin, a novel effector of Rnd2 GTPase, stimulates RhoA activity. J. Biol. Chem. 281, 10355-10364. (Pubitemid 43864574)
77. Tegtmeyer, N., and Backert, S. (2011). Role of Abl and Src family kinases in actin-cytoskeletal rearrangements induced by the Helicobacter pylori CagA protein. Eur. J. Cell Biol. 90, 880-890.
78. Timm, T., Marx, A., Panneerselvam, S., Mandelkow, E., and Mandelkow, E.M. (2008). Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau protein. BMC Neurosci. 9 (Suppl 2), S9.
79. Tomita, H., Takaishi, S., Menheniott, T.R., Yang, X., Shibata, W., Jin, G., Betz, K.S., Kawakami, K., Minamoto, T., Tomasetto, C., et al. (2011). Inhibition of gastric carcinogenesis by the hormone gastrin is mediated by suppression of TFF1 epigenetic silencing. Gastroenterology 140, 879-891.
80. Tsang, Y.H., Lamb, A., Romero-Gallo, J., Huang, B., Ito, K., Peek, R.M., Jr., Ito, Y., and Chen, L.F. (2010). Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation. Oncogene 29, 5643-5650.
81. Tsugawa, H., Suzuki, H., Saya, H., Hatakeyama, M., Hirayama, T., Hirata, K., Nagano, O., Matsuzaki, J., and Hibi, T. (2012). Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe 12, 764-777.
82. Tsutsumi, R., Takahashi, A., Azuma, T., Higashi, H., and Hatakeyama, M. (2006). Focal adhesion kinase is a substrate and downstream effector of SHP-2 complexed with Helicobacter pylori CagA. Mol. Cell. Biol. 26, 261-276.
83. Tsutsumi, R., Masoudi, M., Takahashi, A., Fujii, Y., Hayashi, T., Kikuchi, I., Satou, Y., Taira, M., and Hatakeyama, M. (2013). YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function. Dev. Cell 26, 658-665.
84. Umeda, M., Murata-Kamiya, N., Saito, Y., Ohba, Y., Takahashi, M., and Hatakeyama, M. (2009). Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability. J. Biol. Chem. 284, 22166-22172.
85. Weitzman, M.D., and Weitzman, J.B. (2014). What's the damage? The impact of pathogens on pathways that maintain host genome integrity. Cell Host Microbe 15, this issue, 283-294.
86. Wu, J.N., and Roberts, C.W. (2013). ARID1A mutations in cancer: another epigenetic tumor suppressor? Cancer Discov 3, 35-43.
87. Yamaoka, Y. (2010). Mechanisms of disease: Helicobacter pylori virulence factors. Nat Rev Gastroenterol Hepatol 7, 629-641.
88. Yamashita, K., Sakuramoto, S., and Watanabe, M. (2011). Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surg. Today 41, 24-38.
89. Yaswen, P., and Campisi, J. (2007). Oncogene-induced senescence pathways weave an intricate tapestry. Cell 128, 233-234. (Pubitemid 46123519)
90. Zang, Z.J., Cutcutache, I., Poon, S.L., Zhang, S.L., McPherson, J.R., Tao, J., Rajasegaran, V., Heng, H.L., Deng, N., Gan, A., et al. (2012). Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes. Nat. Genet. 44, 570-574.